Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PCSK9 Turning Point? Sanofi/Regeneron Dangle Lower Price Carrot For Praluent

Mar 13 2018

• By Emily Hayes

Arteries swelling because blood clot by fat cloged made blood flow slowly. Illustration about danger of Cholesterol.

Related Content

Praluent Pricing: Collaboration With ICER Sets A New Standard

Mar 12 2018

Outcomes Claim May Help Amgen Make Case For PCSK9 Inhibitor Repatha

Dec 02 2017

Is Amgen's FOURIER Enough For Physicians, Payers To Expand Repatha Use?

Mar 18 2017

Amgen Faces New ICER Roadblock To Repatha Reimbursement

Jun 15 2017

Amgen Focuses On Pipeline As Mature Products Face Declining Demand

Oct 26 2017

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

Additional Topics

Pricing Strategies Reimbursement Commercial Clinical Trials Research & Development Cardiovascular BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window